G.Barekat Pharm (XTEH:BRKT1) Price-to-Tangible-Book : 17.04 (As of May. 16, 2024)

View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Price-to-Tangible-Book?

As of today (2024-05-16), G.Barekat Pharm's share price is IRR13680.00. G.Barekat Pharm's Tangible Book per Share of Mar. 2017 for the quarter that ended in Mar. 2017 was IRR802.75. Hence, G.Barekat Pharm's Price to Tangible Book Ratio of today is 17.04.

The historical rank and industry rank for G.Barekat Pharm's Price-to-Tangible-Book or its related term are showing as below:

XTEH:BRKT1's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.81
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, G.Barekat Pharm's share price is IRR13680.00. G.Barekat Pharm's Book Value per Sharefor the quarter that ended in Mar. 2017 was IRR916.51. Hence, G.Barekat Pharm's P/B Ratio of today is 14.93.

G.Barekat Pharm Price-to-Tangible-Book Historical Data

The historical data trend for G.Barekat Pharm's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Price-to-Tangible-Book Chart

G.Barekat Pharm Annual Data

Trend

Mar16

Mar17

Price-to-Tangible-Book

1.51

G.Barekat Pharm Semi-Annual Data
	Mar16	Mar17
Price-to-Tangible-Book	-	1.51

Competitive Comparison of G.Barekat Pharm's Price-to-Tangible-Book

For the Biotechnology subindustry, G.Barekat Pharm's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

G.Barekat Pharm's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, G.Barekat Pharm's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where G.Barekat Pharm's Price-to-Tangible-Book falls into.

G.Barekat Pharm Price-to-Tangible-Book Calculation

G.Barekat Pharm's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Mar. 2017 )
	=	13680.00	/	802.753
	=	17.04

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

G.Barekat Pharm Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

G.Barekat Pharm (XTEH:BRKT1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN

Website

http://www.bpharmed.com

G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines